Bioengineering calendar
Wednesday, October 23, 2019
Dr. Miller will discuss results from his study of pre-clinical Alzhimer's disease as part of the BIOCARD project. We will examine the central technologies of Computational Anatomy based on diffeomorphometry for quantifying the anatomical structures of 3T clinical MRI at 1 millimeter scale.
Wednesday, October 30, 2019
Microbial strains have been successfully engineered to produce a wide variety of chemical compounds, several of which have been commercialized. As new products are targeted for biological synthesis, yield is frequently considered a primary driver towards determining feasibility. Theoretical yields can be calculated, establishing an upper limit on the potential conversion
Wednesday, November 6, 2019
BIOE Seminar - Dr. Elsje Pienaar - Computational Agent-Based and Equation-Based Models of TB and HIV
TB and HIV are the leading causes of death from infectious diseases in the world, causing a combined 12 million new infections each year. They are also a deadly combination in co-infected patients, and as many as 70% of TB patients are co-infected with HIV. Both infections require long-term, multi-drug therapy and suffer from emergence of drug resistance. Thus, there is a
Thursday, November 7, 2019
Wednesday, November 13, 2019
There are currently no effective approaches to treat presbyopia, the unavoidable age-related loss of the ability of the eye to accommodate (i.e., to change focus). Most of the current strategies for the correction of presbyopia rely on the assumption that presbyopia is due mainly to age-related changes in the mechanical properties of the crystalline lens of the eye. Howeve
Wednesday, November 20, 2019
Abstract: The fact that the most significant life-threatening diseases of our times such as Cardiovascular Diseases or Cancer remains the number one killer for over a century suggests that, despite the advancements in science and medicine over the years, there is a huge gap in translating these scientific findings to clinical setting. One of the major reasons for this gap
Wednesday, December 4, 2019
Wednesday, December 11, 2019
Wednesday, March 11, 2020
Biologics, products produced from living organisms, have revolutionized treatment of disease. Examples of FDA-approved biologics include therapeutic proteins (e.g. blood clotting factors and antibodies), engineered viruses for gene therapy, and cell therapies. Biologics are addressing previous unmet medical needs, but are challenging to manufacture and therefore high in co
Tuesday, April 7, 2020
Stepping towards this goal of incorporating biochemical data into ASD diagnosis, we analyzed measurements of metabolite concentrations of the folate-dependent one-carbon metabolism and transulfuration pathways taken from blood samples of 83 participants with ASD and 76 age-matched neurotypical peers. Fisher Discriminant Analysis enabled multivariate classification of the p